Manulife (Manufacturers Life Insurance)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-120,164
Closed -$1.49M 4502
2016
Q4
$1.49M Sell
120,164
-422
-0.3% -$5.08K ﹤0.01% 1480
2016
Q3
$1.65M Buy
120,586
+13
+0% +$131 ﹤0.01% 1428
2016
Q2
$891K Buy
120,573
+9,070
+8% +$68K ﹤0.01% 1690
2016
Q1
$691K Buy
111,503
+1,162
+1% +$6.51K ﹤0.01% 1788
2015
Q4
$690 Buy
110,341
+1,144
+1% +$7.51K ﹤0.01% 1817
2015
Q3
$638 Buy
109,197
+2,792
+3% +$21.5K ﹤0.01% 1844
2015
Q2
$880 Sell
106,405
-2,842
-3% -$25.1K ﹤0.01% 1759
2015
Q1
$900 Buy
109,247
+3,837
+4% +$28.4K ﹤0.01% 1750
2014
Q4
$724 Sell
105,410
-2,390
-2% -$14.9K ﹤0.01% 1769
2014
Q3
$582 Buy
107,800
+2,099
+2% +$12.3K ﹤0.01% 1891
2014
Q2
$673K Buy
105,701
+100,299
+1,857% +$690K ﹤0.01% 1839
2014
Q1
$44 Hold
5,402
﹤0.01% 3234
2013
Q4
$37 Sell
5,402
-223,268
-98% -$1.21M ﹤0.01% 3235
2013
Q3
$4.21K Sell
228,670
-232,667
-50% -$4.52M 0.01% 1039
2013
Q2
$8.07M Buy
+461,337
New +$8.18M 0.02% 644

Other funds holding ARIA

Manulife (Manufacturers Life Insurance)'s ARIA Position: Q1 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 120,164 shares — an estimated $1.49M sold.

Manulife (Manufacturers Life Insurance) first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $8.07M in Q2 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 120,164 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.49M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Manulife (Manufacturers Life Insurance)'s Ariad Pharmaceuticals Inc position peaked at $8.07M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2017, filed 15 May 2017.